[go: up one dir, main page]

CA2117367A1 - 3-phenylureidoazepin-2-ones et benzazepin-2-ones utiles comme antagonistes de la cholecystokinine - Google Patents

3-phenylureidoazepin-2-ones et benzazepin-2-ones utiles comme antagonistes de la cholecystokinine

Info

Publication number
CA2117367A1
CA2117367A1 CA002117367A CA2117367A CA2117367A1 CA 2117367 A1 CA2117367 A1 CA 2117367A1 CA 002117367 A CA002117367 A CA 002117367A CA 2117367 A CA2117367 A CA 2117367A CA 2117367 A1 CA2117367 A1 CA 2117367A1
Authority
CA
Canada
Prior art keywords
oxo
phenyl
ureido
nmr
cdci3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002117367A
Other languages
English (en)
Inventor
John A. Lowe, Iii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd Great Britain
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2117367A1 publication Critical patent/CA2117367A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002117367A 1992-01-27 1992-12-16 3-phenylureidoazepin-2-ones et benzazepin-2-ones utiles comme antagonistes de la cholecystokinine Abandoned CA2117367A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82567792A 1992-01-27 1992-01-27
US825,677 1992-01-27

Publications (1)

Publication Number Publication Date
CA2117367A1 true CA2117367A1 (fr) 1993-08-05

Family

ID=25244657

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002117367A Abandoned CA2117367A1 (fr) 1992-01-27 1992-12-16 3-phenylureidoazepin-2-ones et benzazepin-2-ones utiles comme antagonistes de la cholecystokinine

Country Status (19)

Country Link
EP (1) EP0625145A1 (fr)
JP (1) JPH07503465A (fr)
KR (1) KR950700257A (fr)
CN (1) CN1074903A (fr)
AU (1) AU3276193A (fr)
BR (1) BR9207071A (fr)
CA (1) CA2117367A1 (fr)
CZ (1) CZ391092A3 (fr)
FI (1) FI943513A7 (fr)
HU (1) HUT70496A (fr)
IL (1) IL104472A0 (fr)
MX (1) MX9300409A (fr)
NO (1) NO942775L (fr)
NZ (1) NZ245759A (fr)
RU (1) RU94038063A (fr)
TW (1) TW213901B (fr)
WO (1) WO1993015059A1 (fr)
YU (1) YU4393A (fr)
ZA (1) ZA93582B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2097688A1 (es) * 1993-07-14 1997-04-01 Pfizer Hexahidroazepinonas y tetrahidrobenzazepinonas sustituidas.
DE69419157T2 (de) * 1993-07-26 1999-10-14 Pfizer Inc. Tetrahydro-1h-benzazepinone und hexahydro azepinone als selektive cholecystokinin-b rezeptor antagonisten
US5453424A (en) * 1993-11-22 1995-09-26 Merck & Co., Inc. Furanodiazepines
WO1995014671A1 (fr) * 1993-11-22 1995-06-01 Merck & Co., Inc. 3-acylaminobenzazepines
US5977355A (en) * 1994-10-04 1999-11-02 Pfizer Inc. Processes and intermediates for preparing 3-amino-benzo(b)azepinones
ES2171196T3 (es) * 1994-10-14 2002-09-01 Glaxosmithkline Spa Uso de antagonistas del receptor cck-b para el tratamiento de trastornos del sueño.
DE10153348A1 (de) 2001-10-29 2003-05-08 Gruenenthal Gmbh Substituierte Benzo(b)azepin-2-on-Verbindungen
AU2006342209A1 (en) * 2005-06-16 2007-10-25 Novartis Ag Lactam containing HCV inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166357A3 (fr) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzo-lactames condensés et leurs compositions pharmaceutiques
US4767756A (en) * 1987-07-17 1988-08-30 E. R. Squibb & Sons, Inc. 3-substituted benzazepines
EP0322779A3 (fr) * 1987-12-29 1991-05-08 Yoshitomi Pharmaceutical Industries, Ltd. Composés de benzolactame et leur utilisation pharmaceutique
US5206234A (en) * 1990-10-22 1993-04-27 Merck & Co., Inc. Benzolactam analogs as antagonists of cck

Also Published As

Publication number Publication date
WO1993015059A1 (fr) 1993-08-05
FI943513A0 (fi) 1994-07-26
MX9300409A (es) 1993-07-01
HUT70496A (en) 1995-10-30
EP0625145A1 (fr) 1994-11-23
CN1074903A (zh) 1993-08-04
HU9402195D0 (en) 1994-09-28
NO942775D0 (no) 1994-07-26
NZ245759A (en) 1997-06-24
CZ391092A3 (en) 1994-01-19
JPH07503465A (ja) 1995-04-13
KR950700257A (ko) 1995-01-16
TW213901B (fr) 1993-10-01
FI943513L (fi) 1994-07-26
YU4393A (sr) 1996-01-09
IL104472A0 (en) 1993-05-13
BR9207071A (pt) 1995-12-05
AU3276193A (en) 1993-09-01
NO942775L (no) 1994-09-20
RU94038063A (ru) 1996-05-27
ZA93582B (en) 1994-07-27
FI943513A7 (fi) 1994-07-26

Similar Documents

Publication Publication Date Title
US6172239B1 (en) Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin receptors, their preparation and pharamaceutical compositions containing them
DE69330959T2 (de) Benzodiazepinderivate
TW438783B (en) Benzodiazepine derivatives
US5274104A (en) N-substituted heterocyclic derivatives useful in the treatment of cardiovascular disorders
AU670939B2 (en) Benzodiazepine derivatives, compositions containing them and their use in therapy
EP0054862B1 (fr) Dipeptides substitués, leur procédé de préparation, compositions pharmaceutiques les contenant et leur emploi comme inhibiteurs de l'enképhalinase
DE69330714T2 (de) Chinuclidine derivate als substanz p antagonisten
US6187905B1 (en) Alpha-ketoamide derivatives
CA2140640A1 (fr) Antagonistes de la tachykinine
IL101960A (en) Substituted 3-Ú(hetero) arylmethylamino¾-2- (di (hetero) arylmethyl) quinuclidines and pharmaceutical compositions containing them
DE69204040T2 (de) 3-Phenylureido-1,4-Benzodiazepinone und ihre Verwendung als Cholecystokinin- oder Gastrinantagonisten.
CZ287064B6 (cs) N-substituované heterocyklické deriváty, způsob jejich přípravy a farmaceutické kompozice obsahující tyto deriváty
JPS6233141A (ja) ポリペプチド合成の中間体
DK159419B (da) Analogifremgangsmaade til fremstilling af substituerede acylderivater af octahydro-1h-indol-2-carboxylsyrer
CA2415088A1 (fr) Derives d'acides amines bicycliques pontes aza utilises comme antagonistes de l'integrine alpha-4
JPS6069073A (ja) 縮合7員環化合物およびそれを含有してなる高血圧症予防・治療剤
JPS60252495A (ja) スタチンまたはその誘導体を含有するレニン阻害剤
CA2117367A1 (fr) 3-phenylureidoazepin-2-ones et benzazepin-2-ones utiles comme antagonistes de la cholecystokinine
JPS61502818A (ja) シス、エンド−オクタヒドロシクロペンタ〔b〕ピロ−ル−2−カルボキシレ−トの新規製造方法
AU671141B2 (en) Benzodiazepine derivatives
US5484917A (en) Substituted tetrahydrobenzazepinones
CA2075547A1 (fr) Pseudopeptides contenant du trifluoromethyle
US5569662A (en) Quinuclidine derivatives as substance P antagonists
DE60014029T2 (de) Tripeptidische verbindungen mit wirksamkeit als selektive inhibitoren der aminopeptidase a und sie enthaltende pharmazeutische zusammensetzungen
NZ228825A (en) Esters of aminoacyl cyclic amino acid derivatives and pharmaceutical compositions

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued